SectorPharmaceutical
Established Date--
Listing Date27/07/2018
ExchangeNASDAQ Stock Exchange
Full-time Employees5
Fiscal Year Ends31/12
Security TypeCommon stock
Office address4870 Sadler Road, Suite 300, Glen Allen, Virginia 23060
Business
IntroductionAdial Pharmaceuticals, Inc., was incorporated as a Virginia limited liability company in November 2010. The company is a clinical-stage biopharmaceutical company focused on developing therapies to treat or prevent addiction and related diseases. The Company's investigational new drug candidate, AD04, is in development as a therapeutic agent for the treatment of alcohol use disorder (" AUD "). AD04 was recently studied in a Phase 3 clinical trial designated as the ONWARD trial for the potential treatment of AUD in subjects with certain target genotypes identified using a companion diagnostic genetic test.
